|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Cancer Genetics (NASDAQ: CGIX) through any online brokerage.
The latest price target for Cancer Genetics (NASDAQ: CGIX) was reported by Maxim Group on 2018-04-03. The analyst firm set a price target for 0.00 expecting CGIX to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Cancer Genetics (NASDAQ: CGIX) is $5.63 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Cancer Genetics.
There is no upcoming split for Cancer Genetics.